Search TFX
TELEFLEX INC
NYSE · CIK 96943
Last close124.12
Daily change-1.99 (-1.58%)
10 Years gain-17.63%
Dividends TTM1.36 (+0.00%)
Dividend yield1.08%
Fundamental Analysis
TFX · STANDARD
SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 1231
Fundamental
29.1Momentum
0.0Acceleration
11.4Confidence
91.0Annual Revenue18
Quarterly Revenue82
Annual CFO0
Balance SheetAvailable
RankingLimited
Score Breakdown
Growth2.7 / 25
Quality9.2 / 25
Capital Efficiency1.3 / 20
Balance Sheet5.0 / 15
Shareholder Economics9.4 / 10
Forward Indicators0.0 / 5
Signals
Share count reductionDiluted share count declined 1.5158%.
Warnings
Gross margin compression · MEDIUMGross margin compressed by 4.2035 percentage points.
Operating margin compression · MEDIUMOperating margin compressed by 15.897 percentage points.
ROIC declining · MEDIUMROIC declined by 4.2785 percentage points.
Key Metrics
Revenue Growth TTM9.27%OK
Revenue CAGR 3Y-10.62%OK
Gross Margin54.94%OK
Operating Margin1.97%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC0.62%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-1.52%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $1.99B | $1.12B | $118.37M | n/a | n/a | 56.24% | 5.94% | n/a | 1.39% | 44.72M |
| 2025 FY Dec 31, 2024 | $1.70B | $1.04B | $103.65M | n/a | n/a | 61.04% | 6.1% | n/a | 1.15% | 47.09M |
| 2025 FY Dec 31, 2023 | $1.71B | $1.04B | $258.73M | n/a | n/a | 60.74% | 15.11% | n/a | 3.49% | 47.3M |
| 2024 FY Dec 31, 2022 | $2.79B | $1.53B | $499.73M | n/a | n/a | 54.86% | 17.9% | n/a | 7.67% | 47.31M |
| 2023 FY Dec 31, 2021 | $2.81B | $1.55B | $628.10M | n/a | n/a | 55.15% | 22.36% | n/a | 10.28% | 47.43M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $2.25B | sum latest 4 fiscal quarters Revenue | OK | 0000096943-26-000019, 0000096943-26-000050 |
| Revenue Growth TTM | 9.27% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0000096943-26-000019, 0000096943-26-000050 |
| Revenue CAGR 3Y | -10.62% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0000096943-26-000019 |
| Revenue CAGR 5Y | -4.72% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0000096943-26-000019 |
| Gross Profit CAGR 3Y | -9.88% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0000096943-26-000019 |
| Operating Income Growth | -87.94% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0000096943-26-000019, 0000096943-26-000050 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 54.94% | Gross Profit / Revenue | OK | 0000096943-26-000019, 0000096943-26-000050 |
| Operating Margin | 1.97% | Operating Income / Revenue | OK | 0000096943-26-000019, 0000096943-26-000050 |
| ROIC | 0.62% | NOPAT / Average Invested Capital | OK | 0000096943-26-000019, 0000096943-26-000050 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0000096943-26-000095 |
| Current Ratio | 2.6x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.11x | (Cash + Short-term Investments) / Total Debt | OK | 0000096943-26-000095 |
| Revenue per Diluted Share | $51.64 | Revenue / Diluted Shares | OK | 0000096943-26-000019, 0000096943-26-000050 |